Hajar Yaghoobi

6PUBLICATIONS
6CO-AUTHORS
Genomics and transcriptomicsMolecular targetsMedical infection agents (incl. prions)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 17, 2024
In silico identification and in vitro evaluation of MRPS30-DT lncRNA and MRPS30 gene expression in breast cancer.

Nooshafarin Shirani, Roohallah Mahdi-Esferizi, Reza Eshraghi Samani

|Feb 15, 2024
Epigenetic disruption of histone deacetylase-2 accelerated apoptotic signaling and retarded malignancy in gastric cells.

Sayedeh Azimeh Hosseini, Mahdi Ghatrehsamani, Hajar Yaghoobi

|May 11, 2023
MiR-548 K regulatory effect on the ABCG2 gene expression in MDR breast cancer cells.

Mohammadreza Saberiyan, Zahra Ghasemi, Hajar Yaghoobi

|Oct 30, 2022
MiR-548k suppresses apoptosis in breast cancer cells by affecting PTEN/PI3K/AKT signaling pathway.

Mahtab Yadollahi-Farsani, Zeinab Amini-Farsani, Fatemeh Moayedi

|Jun 29, 2022
Designed miR-19a/b sponge induces apoptosis in lung cancer cells through the PI3K-PTEN-Akt pathway regulation.

Sayedeh Azimeh Hosseini, Morvarid Seidi, Hajar Yaghoobi

|Feb 01, 2020
Inhibition of miR-155 in MCF-7 breast cancer cell line by gold nanoparticles functionalized with antagomir and AS1411 aptamer.

Arefeh Kardani, Hajar Yaghoobi, Abbas Alibakhshi

Pageof 1